This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: National Institute of Health and Medical Research, Other. Active years: 2008-2019.
Company Filing History:
2 out of 1,853 
3 out of 834,350 Years Active: 2008-2019
Title: Philippe Gripon: Innovator in Hepatitis B Research
Introduction
Philippe Gripon is a notable inventor based in Rennes, France. He has made significant contributions to the field of medical research, particularly in the area of hepatitis B virus (HBV) diagnostics and treatment. With a total of 3 patents, Gripon's work has the potential to impact the way HBV infections are diagnosed and managed.
Latest Patents
One of Gripon's latest patents focuses on "Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof." This invention relates to a group of synthetic polypeptides derived from the pre-S1 region of HBV. These polypeptides efficiently interfere with the early steps of HBV infection. The peptides can be utilized in diagnostics for the detection of antigens and/or antibodies, providing a valuable tool for medical professionals.
Career Highlights
Throughout his career, Philippe Gripon has worked with esteemed institutions, including the Institut National de la Santé et de la Recherche Médicale. His research has been pivotal in advancing our understanding of hepatitis B and developing innovative solutions for its diagnosis and treatment.
Collaborations
Gripon has collaborated with notable colleagues such as Stephan Urban and Christiane Guguen-Guillouzo. These partnerships have further enriched his research and contributed to the advancements in the field of hepatitis B.
Conclusion
Philippe Gripon's innovative work in hepatitis B research exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations highlight the importance of continued research and development in combating viral infections.